Valion Bio, Inc.
For the period ended Nov 12, 2026. Filed Oct 16, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Nov 12, 2026 · Filed Oct 16, 2026
Use the contents to explore the available documents and sections.
Contents
AVAILABILITY OF ADDITIONAL INFORMATION
We file annual, quarterly and current reports, proxy statements, and other information with the SEC. The SEC maintains a website at http://www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.
We also make available on or through our website at https://valionbio.com/investors/, free of charge, our proxy statements, annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and all amendments to such reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after filing.
By Order of the Board of Directors,
/s/ Melinda Lackey
Melinda Lackey
General Counsel, Senior Vice President, Legal Affairs
October 16, 2026
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.